Effects of L-carnitine against oxidative stress in human hepatocytes: Involvement of peroxisome proliferator-activated receptor alpha

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Li, Jin Lian ^a   Wang, Qiao Yun ^a   Luan, Hai Yun ^a   Kang, Ze Chun ^a   Wang, Chun Bo ^b  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Antioxidant effect; HL7702 cells; Hydrogen peroxide; L carnitine; Peroxisome proliferator activated receptor alpha

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ACYL COENZYME A OXIDASE; BETA ACTIN; CARNITINE; CARNITINE PALMITOYLTRANSFERASE I; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; MALONALDEHYDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; CARNITINE PALMITOYLTRANSFERASE; INDOLE DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER CELL; LIVER PROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ACYL-COA OXIDASE; CARNITINE; CARNITINE O-PALMITOYLTRANSFERASE; CATALASE; CELL LINE; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; HYDROGEN PEROXIDE; INDOLES; MALONDIALDEHYDE; OXIDATIVE STRESS; PPAR ALPHA; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84862817269     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-32     Document Type: Article

References (34)

1. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Rebouche CJ, Ann N Y Acad Sci 2004 1033 30 41 10.1196/annals.1320.003 15591001 (Pubitemid 39656736)
2. Antioxidant and antiradical activities of L-carnitine. Gülçin I, Life Sci 2006 78 803 811 10.1016/j.lfs.2005.05.103 16253281 (Pubitemid 43082302)
3. L-carnitine inhibits hepatocarcinogenesis via protection of mitochondria. Chang B, Nishikawa M, Nishiguchi S, Inoue M, Int J Cancer 2005 113 719 729 10.1002/ijc.20636 15499623 (Pubitemid 40101252)
4. L-carnitine alleviates alcohol-induced liver damage in rats: role of tumour necrosis factor-alpha. Bykov I, Järveläinen H, Lindros K, Alcohol Alcohol 2003 38 400 406 12915513 (Pubitemid 37063378)
5. Carnitine in the treatment of valproic acid-induced toxicity. Lheureux PE, Hantson P, Clin Toxicol (Phila) 2009 47 101 111 10.1080/15563650902752376
6. L-carnitine delays the killing of cultured hepatocytes by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Snyder JW, Kyle ME, Ferraro TN, Arch Biochem Biophys 1990 276 132 138 10.1016/0003-9861(90)90019-U 2297220 (Pubitemid 20041826)
7. Role of free radicals in liver diseases. Pablo M, Hepatol Int 2009 3 526 536 10.1007/s12072-009-9158-6
8. Pathophysiological basis for antioxidant therapy in chronic liver disease. Medina J, Moreno-Otero R, Drugs 2005 65 2445 2461 10.2165/00003495- 200565170-00003 16296871 (Pubitemid 41697314)
9. Effect of L-carnitine on liver cell membranes in ethanol-intoxicated rats. Dobrzyska I, Szachowicz-Petelska B, Skrzydlewska E, Figaszewski Z, Chem Biol Interact 2010 188 44 51 10.1016/j.cbi.2010.07.004 20637186
10. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Issemann I, Green S, Nature 1990 347 645 650 10.1038/347645a0 2129546 (Pubitemid 20356241)
11. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W, Endocrinology 1996 137 354 366 10.1210/en.137.1.354 8536636 (Pubitemid 26005011)
12. The role of PPAR activation in liver and muscle. Burri L, Thoresen GH, Berge RK, PPAR Research 2010 2010 ii: 542359
13. Peroxisome proliferator-activated receptor-alpha protects against alcohol-induced liver damage. Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T, Hepatology 2004 40 972 980 15382117 (Pubitemid 39288131)
14. PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Toyama T, Nakamura H, Harano Y, Yamauchi N, Morita A, Kirishima T, Minami M, Itoh Y, Okanoue T, Biochem Biophys Res Commun 2004 324 697 704 10.1016/j.bbrc.2004.09.110 15474484 (Pubitemid 39345573)
15. Peroxisome proliferator-activated receptor alpha plays a crucial role in L-carnitine anti-apoptosis effect in renal tubular cells. Chen HH, Sue YM, Chen CH, Hsu YH, Hou CC, Cheng CY, Lin SL, Tsai WL, Chen TW, Chen TH, Nephrol Dial Transplant 2009 24 3042 3049 10.1093/ndt/gfp258 19491382
16. Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis. Cardell LO, Hägge M, Uddman R, Adner M, Respir Res 2005 6 132 10.1186/1465-9921-6-132 16271155 (Pubitemid 41645676)
17. Effect of polyphenol-rich extract from walnut on diet-induced hypertriglyceridemia in mice via enhancement of fatty acid oxidation in the liver. Shimoda H, Tanaka J, Kikuchi M, Fukuda T, Ito H, Hatano T, Yoshida T, J Agric Food Chem 2009 57 1786 1792 10.1021/jf803441c 19256553
18. Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures. Bjork JA, Wallace KB, Toxicol Sci 2009 111 89 99 10.1093/toxsci/kfp093 19407336
19. The mechanisms of action of PPARs. Berger J, Moller DE, Annu Rev Med 2002 53 409 435 10.1146/annurev.med.53.082901.104018 11818483 (Pubitemid 34177889)
20. Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liver. Inoue I, Noji S, Awata T, Takahashi K, Nakajima T, Sonoda M, Komoda T, Katayama S, Life Sci 1998 63 135 144 10.1016/S0024-3205(98)00249-5 9674948 (Pubitemid 28298667)
21. The antioxidant and prooxidant activity of some B vitamins and vitamin-like compounds. Hu ML, Chen YK, Lin YF, Chem Biol Interact 1995 97 63 73 10.1016/0009-2797(95)03608-8 7767942
22. Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells. De Bleser PJ, Xu G, Rombouts K, Rogiers V, Geerts A, J Biol Chem 1999 274 33881 33887 10.1074/jbc.274.48.33881 10567349 (Pubitemid 129511715)
23. Current concepts in the pathogenesis of alcoholic liver injury. Tsukamoto H, Lu SC, FASEB J 2001 15 1335 1349 10.1096/fj.00-0650rev 11387231 (Pubitemid 32531812)
24. CYP2E1 and oxidative liver injury by alcohol. Lu Y, Cederbaum AI, Free Radic Biol Med 2008 44 723 738 10.1016/j.freeradbiomed.2007.11.004 18078827
25. Effects of L-carnitine on neutrophil-mediated ischemia-reperfusion injury in rat stomach. Derin N, Agac A, Bayram Z, Asar M, Izgut-Uysal VN, Cell Biochem Funct 2006 24 437 442 10.1002/cbf.1251 16130180 (Pubitemid 44379583)
26. Protective effects of carnitine in an experimental ischemia-reperfusion injury. Atila K, Coker A, Sagol O, Coker I, Topalak O, Astarcioglu H, Karademir S, Astarcioglu I, Clin Nutr 2002 21 309 313 10.1054/clnu.2002.0544 12135591 (Pubitemid 34846886)
27. Reduced expression of peroxisome proliferator-activated receptor-a may have an important role in the development of non-alcoholic fatty liver disease. Yeon JE, Choi KM, Baik SH, Kim KO, Lim HJ, Park KH, Kim JY, Park JJ, Kim JS, Bak YT, Byun KS, Lee CH, J Gastroenterol Hepatol 2004 19 799 804 10.1111/j.1440-1746.2004.03349.x 15209628 (Pubitemid 38981403)
28. A critical role for the peroxisome proliferator-activated receptor (PPAR) in the cellular fasting response: the PPAR-null mouse as a model of fatty acid oxidation disorders. Leone TC, Weinheimer CJ, Kelly DP, Proc Natl Acad Sci USA 1999 96 7473 7478 10.1073/pnas.96.13.7473 10377439 (Pubitemid 29299686)
29. Peroxisome proliferator activated receptors: a nuclear receptor signaling pathway in lipid physiology. Lemberger T, Desvergne B, Wahli W, Annu Rev Cell Dev Biol 1996 12 335 363 10.1146/annurev.cellbio.12.1.335 8970730 (Pubitemid 26422717)
30. The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. McGarry JD, Brown NF, Eur J Biochem 1997 244 1 14 10.1111/j.1432-1033.1997.00001.x 9063439 (Pubitemid 27079689)
31. Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Qi C, Zhu Y, Reddy JK, Cell Biochem Biophys 2000 32 187 204 10.1385/CBB:32:1-3:187 11330046
32. L-Carnitine induces recovery of liver lipid metabolism in cancer cachexia. Silvério R, Laviano A, Fanelli FR, Seelaender M, Amino Acids 2011
33. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. Hyslop PA, Hinshaw DB, Halsey WA Jr, Schraufstätter IU, Sauerheber RD, Spragg RG, Jackson JH, Cochrane CG, J Biol Chem 1988 263 1665 1675 3338986 (Pubitemid 18052113)
34. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Girnun GD, Domann FE, Moore SA, Robbins ME, Mol Endocrinol 2002 16 2793 2801 10.1210/me.2002-0020 12456800 (Pubitemid 36020658)